Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precision Biosciences (DTIL) Prepaid Assets (2018 - 2025)

Historic Prepaid Assets for Precision Biosciences (DTIL) over the last 8 years, with Q3 2025 value amounting to $5.9 million.

  • Precision Biosciences' Prepaid Assets fell 1766.94% to $5.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.9 million, marking a year-over-year decrease of 1766.94%. This contributed to the annual value of $6.4 million for FY2024, which is 776.31% up from last year.
  • Latest data reveals that Precision Biosciences reported Prepaid Assets of $5.9 million as of Q3 2025, which was down 1766.94% from $7.4 million recorded in Q2 2025.
  • In the past 5 years, Precision Biosciences' Prepaid Assets ranged from a high of $21.2 million in Q3 2021 and a low of $4.6 million during Q1 2025
  • Moreover, its 5-year median value for Prepaid Assets was $8.1 million (2023), whereas its average is $9.4 million.
  • As far as peak fluctuations go, Precision Biosciences' Prepaid Assets soared by 20256.86% in 2021, and later plummeted by 6544.11% in 2022.
  • Quarter analysis of 5 years shows Precision Biosciences' Prepaid Assets stood at $17.4 million in 2021, then crashed by 65.44% to $6.0 million in 2022, then decreased by 0.8% to $6.0 million in 2023, then increased by 7.76% to $6.4 million in 2024, then fell by 9.07% to $5.9 million in 2025.
  • Its last three reported values are $5.9 million in Q3 2025, $7.4 million for Q2 2025, and $4.6 million during Q1 2025.